FAST-FORWARD vs HAI5
Recruiting · NCT06345534 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Ghent
View the official record on ClinicalTrials.gov →Interventions studied
Questionnaire
What this trial is about
Randomized comparison between the FAST-FORWARD schedule and the HAI5 schedule for breast cancer radiotherapy in 5 fractions.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- histopathological diagnosis of breast cancer
- age 18 years or older
- male or female
- treated with breast conserving surgery or mastectomy with curative intent
- multidisciplinary decision of adjuvant radiotherapy after surgery
Exclusion criteria
- distant metastases
- decision of preoperative radiotherapy
- decision of partial breast irradiation
- positive resection margins ('ink on tumour')
- indication for boost on lymph node(s)
- history of thoracic or ipsilateral axillary radiotherapy (including radiotherapy of the contralateral breast or chest wall)
- need for bilateral irradiation
- breast reconstruction or expander
- patients unlikely to comply with the protocol (e.g. inability or unwillingness to complete the questionnaires at different time points).
Where it is running
2 locations listed.
- Universitary Hospital - Ghent, Belgium
- University Hospital Ghent - Ghent, Belgium